REFERENCES
1. Hu C. Grants supporting research in China. Eur Heart J .
2018;39:2342-2344.
2. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of
COVID-19. Nat Med . 2022;28:583-590.
3. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis,
and blood pressure-electrolyte homeostasis. N Engl J Med .
1985;3131:1330-1340.
4. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth
factor axis: A review of atherosclerosis and restenosis. Circ
Res . 2000;86:125-130.
5. Bush EW, McKinsey TA. Protein acetylation in the cardiorenal axis:
the promise of histone deacetylase inhibitors. Circ Res .
2010;106:272-284.
6. Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental
mechanism signaling danger to the vulnerable vasculature. Circ
Res . 2010;106:842-853. l
7.El Refaey M, Musa H, Murphy NP, et al. Protein Phosphatase 2A
Regulates Cardiac Na+ Channels. Circ Res .
2019;124:737-746.
8.Emami H, Singh P, MacNabb M, et al. Splenic metabolic activity
predicts risk of future cardiovascular events: demonstration of a
cardiosplenic axis in humans. JACC Cardiovasc Imaging .
2015;8:121-130.
9.Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD.
Remodeling of the mononuclear phagocyte network underlies chronic
inflammation and disease progression in heart failure: critical
importance of the cardiosplenic axis. Circ Res . 2014;114:266-282.
10.Wang L, Zhang YL, Lin QY, et al. CXCL1-CXCR2 axis mediates
angiotensin II-induced cardiac hypertrophy and remodelling through
regulation of monocyte infiltration. Eur Heart J .
2018;39:1818-1831.
11.Döring Y, Noels H, van der Vorst EPC, et al. Vascular CXCR4 Limits
Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse
and Human Studies. Circulation . 2017;136:388-403.
12.Seeger FH, Rasper T, Fischer A, et al. Heparin disrupts the
CXCR4/SDF-1 axis and impairs the functional capacity of bone
marrow-derived mononuclear cells used for cardiovascular repair.Circ Res . 2012;111:854-862.
13.Zhuang R, Chen J, Cheng HS, et al. Perivascular Fibrosis Is Mediated
by a KLF10-IL-9 Signaling Axis in CD4+ T Cells. Circ Res .
2022;130:1662-1681.
14.Abohashem S, Osborne MT, Dar T, et al. A leucopoietic-arterial axis
underlying the link between ambient air pollution and cardiovascular
disease in humans. Eur Heart J . 2021;42:761-772.
15.Hung MY, Witztum JL, Tsimikas S. New therapeutic targets for
calcific aortic valve stenosis: the
lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized
phospholipid axis. J Am Coll Cardiol . 2014;63:478-480.
16.Paulin R, Sutendra G, Gurtu V, et al. A miR-208-Mef2 axis drives the
decompensation of right ventricular function in pulmonary hypertension.Circ Res . 2015;116:56-69.
17.Zhang Y, Wang Y, Zhang L, et al. Reduced Platelet miR-223 Induction
in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a
miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis. Circ Res .
2020;127:855-873.
18.Liu X, Guo JW, Lin XC, et al. Macrophage NFATc3 prevents foam cell
formation and atherosclerosis: evidence and mechanisms. Eur Heart
J . 2021;42:4847-4861.
19.Ljubojevic-Holzer S, Herren AW, Djalinac N, et al. CaMKIIδC Drives
Early Adaptive Ca2+ Change and Late Eccentric Cardiac
Hypertrophy. Circ Res . 2020;127:1159-1178.
20.Cui H, Chen Y, Li K, et al. Untargeted metabolomics identifies
succinate as a biomarker and therapeutic target in aortic aneurysm and
dissection. Eur Heart J . 2021;42:4373-4385.
21. Xiao N, Liu TL, Li H, et al. Low Serum Uric Acid Levels Promote
Hypertensive Intracerebral Hemorrhage by Disrupting the Smooth Muscle
Cell-Elastin Contractile Unit and Upregulating the Erk1/2-MMP Axis.Transl Stroke Res . 2020;11:1077-1094.
22. Li Q, Huang K, Ma T, et al. Metoprolol Protects Against Arginine
Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by
Regulating the Sirt1/p53/p21 Axis. Cardiovasc Toxico .
2022;22:99-107.
23.Zhang H, Xu A, Sun X, et al. Self-Maintenance of Cardiac Resident
Reparative Macrophages Attenuates Doxorubicin-Induced Cardiomyopathy
Through the SR-A1-c-Myc Axis. Circ Res . 2020;127:610-627.
24.El-Sammak H, Yang B, Guenther S, Chen W, Marín-Juez R, Stainier DYR.
A Vegfc-Emilin2a-Cxcl8a Signaling Axis Required for Zebrafish Cardiac
Regeneration. Circ Res . 2022;130:1014-1029
25.Zheng Y, Huang S, Zhang J, et al. Melatonin alleviates vascular
endothelial cell damage by regulating an autophagy-apoptosis axis in
Kawasaki disease. Cell Prolif . 2022;55:e13251.
26. Ma QX, Zhu WY, Lu XC, et al. BCAA-BCKA axis regulates WAT browning
through acetylation of PRDM16. Nat Metab . 2022;4:106-122.
27. Lin DS, Zhang CY, Li L, Ye GH, Jiang LP, Jin Q. Circ_ROBO2/miR-149
Axis Promotes the Proliferation and Migration of Human Aortic Smooth
Muscle Cells by Activating NF-κB Signaling. Cytogenet Genome Res .
2021;161:414-424.
28. Perry RJ, Peng L, Barry NA, et al. Acetate mediates a
microbiome-brain-β-cell axis to promote metabolic syndrome.Nature . 2016;534:213-217.
29. Weng G, Gu M, Zhang Y, Zhao G, Gu Y. LINC01123 promotes cell
proliferation and migration via regulating miR-1277-5p/KLF5 axis in
ox-LDL-induced vascular smooth muscle cells. J Mol Histol .
2021;52:943-953.
30. Peng W, Li T, Pi S, Huang L, Liu Y. Suppression of circular RNA
circDHCR24 alleviates aortic smooth muscle cell proliferation and
migration by targeting miR-149-5p/MMP9 axis. Biochem Biophys Res
Commun . 2020;529:753-759.
31. Gu J, Shi JZ, Wang YX, et al. LncRNA FAF attenuates
hypoxia/ischaemia-induced pyroptosis via the miR-185-5p/PAK2 axis in
cardiomyocytes. J Cell Mol Med . 2022;26:2895-2907.
32. Ding S, Abudupataer M, Zhou Z, et al. Histamine deficiency
aggravates cardiac injury through miR-206/216b-Atg13 axis-mediated
autophagic-dependant apoptosis. Cell Death Dis . 2018;9:694.
33. Chen Q, Lin G, Lin L, et al. LncRNA XR_596701 protects H9c2 cells
against intermittent hypoxia-induced injury through regulation of the
miR-344b-5p/FAIM3 axis. Cell Death Discov . 2022;8:42.
34. Xiong X, Liu J, He Q, et al. Long non-coding RNA NORAD aggravates
acute myocardial infarction by promoting fibrosis and apoptosis via
miR-577/COBLL1 axis. Environ Toxicol . 2021;36:2256-2265.
35. Huang HS, Huang XY, Yu HZ, Xue Y, Zhu PL. Circular RNA circ-RELL1
regulates inflammatory response by miR-6873-3p/MyD88/NF-κB axis in
endothelial cells. Biochem Biophys Res Commun . 2020;525:512-519.
36. Yang GS, Zheng B, Qin Y, et al. Salvia miltiorrhiza-derived miRNAs
suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA
axis. Theranostics . 2020;10:7787-7811.
37. Liu J, Wang C, Li J, et al. Autophagy blockage promotes the
pyroptosis of ox-LDL-treated macrophages by modulating the p62/Nrf2/ARE
axis. J Physiol Biochem . 2021;77:419-429.
38. Shiroorkar PN, Afzal O, Kazmi I, et al. Cardioprotective Effect of
Tangeretin by Inhibiting PTEN/AKT/mTOR Axis in Experimental
Sepsis-Induced Myocardial Dysfunction. Molecules . 2020;25:5622.
39. Nie T, Hui X, Mao L, et al. Harmine Induces Adipocyte Thermogenesis
through RAC1-MEK-ERK-CHD4 Axis. Sci Rep . 2016;6:36382.
40. Ling S, Ni RZ, Yuan Y, et al. Natural compound bavachalcone promotes
the differentiation of endothelial progenitor cells and
neovascularization through the RORα-erythropoietin-AMPK axis.Oncotarget . 2017;8:86188-86205.
41. Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal
modulates TH17 axis and disease. Nature .
2017;551:585-589.
42. Peng F, Zhang N, Wang C, et al. Aconitine induces cardiomyocyte
damage by mitigating BNIP3-dependent mitophagy and the TNFα-NLRP3
signalling axis. Cell Prolif . 2020;53:e12701.
43. Santisteban MM, Kim S, Pepine CJ, Raizada MK. Brain-Gut-Bone Marrow
Axis: Implications for Hypertension and Related Therapeutics. Circ
Res . 2016;118:1327-1336.
44. Tahsili-Fahadan P, Geocadin RG. Heart-Brain Axis: Effects of
Neurologic Injury on Cardiovascular Function. Circ Res .
2017;120:559-572.
45. Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M.
Targeting the CCL2-CCR2 axis for atheroprotection. Eur Heart J .
2022;43:1799-1808.
46. Crea F. New therapeutic targets to reduce inflammation-associated
cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5. Eur
Heart J . 2022;43:1777-1781.
47. Mohanta SK, Peng L, Li Y, et al. Neuroimmune cardiovascular
interfaces control atherosclerosis. Nature . 2022;605:152-159.
48. Giussani DA. Breath of Life: Heart Disease Link to Developmental
Hypoxia. Circulation . 2021;144:1429-1443.
49. Tang WH, Kitai T, Hazen SL. Gut Microbiota in Cardiovascular Health
and Disease. Circ Res . 2017;120:1183-1196.
50. King JB, Pinheiro LC, Bryan Ringel J, et al. Multiple Social
Vulnerabilities to Health Disparities and Hypertension and Death in the
REGARDS Study. Hypertension . 2022;79:196-206.
51. van Laer SD, Snijder MB, Agyemang C, Peters RJ, van den Born BH.
Ethnic differences in hypertension prevalence and contributing
determinants - the HELIUS study. Eur J Prev Cardiol .
2018;25:1914-1922.
52. Rietveld CA, Medland SE, Derringer J, et al. GWAS of 126,559
individuals identifies genetic variants associated with educational
attainment. Science . 2013;340:1467-1471.
53. Okbay A, Beauchamp JP, Fontana MA, et al. Genome-wide association
study identifies 74 loci associated with educational attainment.Nature . 2016;533:539-542.
54. Okbay A, Wu Y, Wang N, et al. Polygenic prediction of educational
attainment within and between families from genome-wide association
analyses in 3 million individuals. Nat Genet . 2022;54:437-449.
55. Younan D, Wang X, Millstein J, et al. Air quality improvement and
cognitive decline in community-dwelling older women in the United
States: A longitudinal cohort study. PLoS Med . 2022;19:e1003893.
56. Hu CS, Tkebuchava T. SEEDi1.0-3.0 strategies for
major noncommunicable diseases in China. J Integr Med .
2017;15:265-269.
57. Hu CS, Tkebuchava T. E-noise: An increasingly relevant health risk.J Integr Med . 2019;17:311-314.
58. Chen R, Jiang Y, Hu J, et al. Hourly Air Pollutants and Acute
Coronary Syndrome Onset In 1.29 Million Patients. Circulation .
2022;145:1749-1760.
59. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors,
cardiovascular disease, and mortality in 155 722 individuals from 21
high-income, middle-income, and low-income countries (PURE): a
prospective cohort study. Lancet . 2020;395:795-808.
60. Jowell AR, Sarma AA, Gulati M, et al. Interventions to Mitigate Risk
of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review.JAMA Cardiol . 2022;7:346-355.
61. Benagiano M, Mancuso S, Brosens JJ, Benagiano G. Long-Term
Consequences of Placental Vascular Pathology on the Maternal and
Offspring Cardiovascular Systems. Biomolecules . 2021;11:1625.
62. Yang H, Wu J, Huang X, et al. ABO genotype alters the gut microbiota
by regulating GalNAc levels in pigs. Nature . 2022;606:358-367.
63. Bai PY, Chen SQ, Jia DL, et al. Environmental eustress improves
postinfarction cardiac repair via enhancing cardiac macrophage survival.Sci Adv . 2022;8:eabm3436.
64. Coppini R, Santini L, Olivotto I, Ackerman MJ, Cerbai E.
Abnormalities in sodium current and calcium homoeostasis as drivers of
arrhythmogenesis in hypertrophic cardiomyopathy. Cardiovasc Res .
2020;116:1585-1599.
65. Crotti L, Odening KE, Sanguinetti MC. Heritable arrhythmias
associated with abnormal function of cardiac potassium channels.Cardiovasc Res . 2020;116:1542-1556.
66. Garshick MS, Nikain C, Tawil M, et al. Reshaping of the
gastrointestinal microbiome alters atherosclerotic plaque inflammation
resolution in mice. Sci Rep . 2021;11:8966.
67. Guo X, Dai X, Zhou T, et al. Mosaic loss of human Y chromosome:
what, how and why. Hum Genet . 2020;139:421-446.
68. Cooke CM, Davidge ST. Advanced maternal age and the impact on
maternal and offspring cardiovascular health. Am J Physiol Heart
Circ Physiol . 2019;317:H387-H394.
69. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with
isolated congenital coronary artery anomalies. J Am Coll Cardiol .
1992;20:640-647.
70. Talmor-Barkan Y, Bar N, Shaul AA, et al. Metabolomic and microbiome
profiling reveals personalized risk factors for coronary artery disease.Nat Med . 2022;28:295-302.
71. Wang N, Sun Y, Zhang H, et al. Long-term night shift work is
associated with the risk of atrial fibrillation and coronary heart
disease. Eur Heart J . 2021;42:4180-4188.
72. Zhang SL, Bai L, Goel N, et al. Human and rat gut microbiome
composition is maintained following sleep restriction. Proc Natl
Acad Sci U S A . 2017;114:E1564-E1571.
73. Grosicki GJ, Riemann BL, Flatt AA, Valentino T, Lustgarten MS.
Self-reported sleep quality is associated with gut microbiome
composition in young, healthy individuals: a pilot study. Sleep
Med . 2020;73:76-81.
74. Maki KA, Burke LA, Calik MW, et al. Sleep fragmentation increases
blood pressure and is associated with alterations in the gut microbiome
and fecal metabolome in rats. Physiol Genomics . 2020;52:280-292.
75. Liu Z, Wei ZY, Chen J, et al. Acute Sleep-Wake Cycle Shift Results
in Community Alteration of Human Gut Microbiome. mSphere .
2020;5:e00914-e00919.
76. Jiang Z, Zhuo LB, He Y, et al.The gut microbiota-bile acid axis
links the positive association between chronic insomnia and
cardiometabolic diseases. Nat Commun . 2022;13:3002.
77. Durgan DJ, Ganesh BP, Cope JL, et al. Role of the Gut Microbiome in
Obstructive Sleep Apnea-Induced Hypertension. Hypertension .
2016;67:469-474.
78. Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological
Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific
Statement From the American Heart Association. Circulation .
2021;143:e763-e783.
79. Levine GN, Lange RA, Bairey-Merz CN, et al. American Heart
Association Council on Clinical Cardiology; Council on Cardiovascular
and Stroke Nursing; and Council on Hypertension. Meditation and
Cardiovascular Risk Reduction: A Scientific Statement From the American
Heart Association. J Am Heart Assoc . 2017;6:e002218.
80. Ponte Márquez PH, Feliu-Soler A, Solé-Villa MJ, et al. Benefits of
mindfulness meditation in reducing blood pressure and stress in patients
with arterial hypertension. J Hum Hypertens . 2019;33:237-247.
81. Krittanawong C, Kumar A, Wang Z, et al. Meditation and
Cardiovascular Health in the US. Am J Cardiol . 2020;131:23-26.
82. Aggarwal M, Bozkurt B, Panjrath G, et al. American College of
Cardiology’s Nutrition and Lifestyle Committee of the Prevention of
Cardiovascular Disease Council. Lifestyle Modifications for Preventing
and Treating Heart Failure. J Am Coll Cardiol . 2018;72:2391-2405.
83. Jia W, Zhen J, Liu A, et al. Long-Term Vegan Meditation Improved
Human Gut Microbiota. Evid Based Complement Alternat Med .
2020;2020:9517897.
84. Leonardi I, Gao IH, Lin WY, et al. Mucosal fungi promote gut barrier
function and social behavior via Type 17 immunity. Cell .
2022;185:831-846.e14.
85. Mayneris-Perxachs J, Castells-Nobau A, Arnoriaga-Rodríguez M, et al.
Microbiota alterations in proline metabolism impact depression.Cell Metab . 2022;34:681-701.e10.
86. Carloni S, Bertocchi A, Mancinelli S, et al. Identification of a
choroid plexus vascular barrier closing during intestinal inflammation.Science . 2021;374:439-448.
87. Barki N, Bolognini D, Börjesson U, et al. Chemogenetics defines a
short-chain fatty acid receptor gut-brain axis. Elife .
2022;11:e73777.
88. Klopack ET, Crimmins EM, Cole SW, Seeman TE, Carroll JE. Social
stressors associated with age-related T lymphocyte percentages in older
US adults: Evidence from the US Health and Retirement Study. Proc
Natl Acad Sci U S A . 2022;119:e2202780119.
89. Cooper DM, Radom-Aizik S. Exercise-associated prevention of adult
cardiovascular disease in children and adolescents: monocytes, molecular
mechanisms, and a call for discovery. Pediatr Res .
2020;87:309-318.
90. Xia WJ, Xu ML, Yu XJ, et al. Antihypertensive effects of exercise
involve reshaping of gut microbiota and improvement of gut-brain axis in
spontaneously hypertensive rat. Gut Microbes . 2021;13:1-24.
91. Li Y, Zafar S, Salih Ibrahim RM, et al. Exercise and food supplement
of vitamin C ameliorate hypertension through improvement of gut
microflora in the spontaneously hypertensive rats. Life Sci .
2021;269:119097.
92. Liu Z, Liu HY, Zhou H, et al. Moderate-Intensity Exercise Affects
Gut Microbiome Composition and Influences Cardiac Function in Myocardial
Infarction Mice. Front Microbiol . 2017;8:1687.
93. Zhou Q, Deng J, Pan X, et al. Gut microbiome mediates the protective
effects of exercise after myocardial infarction. Microbiome .
2022;10:82.
94. Taniguchi H, Tanisawa K, Sun X, et al. Effects of short-term
endurance exercise on gut microbiota in elderly men. Physiol Rep .
2018;6:e13935.
95. Huang WC, Tung CL, Yang YSH, Lin IH, Ng XE, Tung YT. Endurance
exercise ameliorates Western diet-induced atherosclerosis through
modulation of microbiota and its metabolites. Sci Rep .
2022;12:3612.
96. Li VL, He Y, Contrepois K, et al. An exercise-inducible metabolite
that suppresses feeding and obesity. Nature . 2022;606:785-790.
97. Lynn MA, Eden G, Ryan FJ, et al. The composition of the gut
microbiota following early-life antibiotic exposure affects host health
and longevity in later life. Cell Rep . 2021;36:109564.
98. Cabreiro F, Au C, Leung KY, et al. Metformin retards aging in C.
elegans by altering microbial folate and methionine metabolism.Cell . 2013;153:228-239.
99. Pryor R, Norvaisas P, Marinos G, et al. Host-Microbe-Drug-Nutrient
Screen Identifies Bacterial Effectors of Metformin Therapy. Cell .
2019;178:1299-1312.e29.
100. Thomas RL, Jiang L, Adams JS, et al. Vitamin D metabolites and the
gut microbiome in older men. Nat Commun . 2020;11:5997.
101. Gould AL, Zhang V, Lamberti L, et al. Microbiome interactions shape
host fitness. Proc Natl Acad Sci U S A . 2018;115:E11951- E11960.
102. Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the
gut-brain axis. Science . 2021;374:1087-1092.
103. Kim B, Kanai MI, Oh Y, et al. Response of the microbiome-gut-brain
axis in Drosophila to amino acid deficit. Nature .
2021;593:570-574.
104. Liu X, Li X, Xia B, et al. High-fiber diet mitigates maternal
obesity-induced cognitive and social dysfunction in the offspring via
gut-brain axis. Cell Metab . 2021;33:923-938.e6.
105. Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary
preferences mediate autism-gut microbiome associations. Cell .
2021;184:5916-5931.e17.
106. Wu WL, Adame MD, Liou CW, et al. Microbiota regulate social
behaviour via stress response neurons in the brain. Nature .
2021;595:409-414.
107. Zhu S, Xu K, Jiang Y, et al. The gut microbiome in subclinical
atherosclerosis: a population-based multiphenotype analysis.Rheumatology (Oxford) . 2021;61:258-269.
108. Beale AL, O’Donnell JA, Nakai ME, et al. The Gut Microbiome of
Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc .
2021;10:e020654.
109. Israr MZ, Bernieh D, Salzano A, et al. Association of gut-related
metabolites with outcome in acute heart failure. Am Heart J .
2021;234:71-80.
110. Brunt VE, Gioscia-Ryan RA, Richey JJ, et al. Suppression of the gut
microbiome ameliorates age-related arterial dysfunction and oxidative
stress in mice. J Physiol . 2019;597:2361-2378.
111. Gacesa R, Kurilshikov A, Vich Vila A, et al. Environmental factors
shaping the gut microbiome in a Dutch population. Nature .
2022;604:732-739.
112. Lehtisalo J, Rusanen M, Solomon A, et al. Effect of a multi-domain
lifestyle intervention on cardiovascular risk in older people: the
FINGER trial. Eur Heart J . 2022;43:2054-2061.
113. Walker RL, Vlamakis H, Lee JWJ, et al. Population study of the gut
microbiome: associations with diet, lifestyle, and cardiometabolic
disease. Genome Med . 2021;13:188.
114. Gruber J, Kennedy BK. Microbiome and Longevity: Gut Microbes Send
Signals to Host Mitochondria. Cell . 2017;169:1168-1169.
115. Kundu P, Lee HU, Garcia-Perez I, et al. Neurogenesis and
prolongevity signaling in young germ-free mice transplanted with the gut
microbiota of old mice. Sci Transl Med . 2019;11:eaau4760.
116. Bárcena C, Valdés-Mas R, Mayoral P, et al. Healthspan and lifespan
extension by fecal microbiota transplantation into progeroid mice.Nat Med . 2019;25:1234-1242.
117. Lurbe E, Ingelfinger J. Developmental and Early Life Origins of
Cardiometabolic Risk Factors: Novel Findings and Implications.Hypertension . 2021;77:308-318.
118. Laroia G, Horne BD, Esplin S, Ramaswamy VK. A unified health
algorithm that teaches itself to improve health outcomes for every
individual: How far into the future is it? Digit Health .
2022;8:20552076221074126.
119. Ng R, Sutradhar R, Kornas K, et al. Development and Validation of
the Chronic Disease Population Risk Tool (CDPoRT) to Predict Incidence
of Adult Chronic Disease. JAMA Netw Open . 2020;3:e204669.
120. Vanlandewijck M, He L, Mäe MA, et al. A molecular atlas of cell
types and zonation in the brain vasculature. Nature .
2018;554:475-480.
121. Litviňuková M, Talavera-López C, Maatz H, et al. Cells of the adult
human heart. Nature . 2020;588:466-472.
122. Garcia FJ, Sun N, Lee H, et al. Single-cell dissection of the human
brain vasculature. Nature . 2022;603:893-899.